Regulation of Immunoglobulin free light chains in RA patients upon rituximab (anti-CD20) treatmant correlates with changes in disease activity

  • Floris Lafeber (Speaker)

Activity: Talk or presentation › Oral presentation › Academic

Period16 Dec 2009
Event titleNVVI (Noordwijkerhout, NL)
Event typeSeminar